1. Introduction {#sec0005}
===============

Porcine Epidemic Diarrhea Virus (PEDV) is an enveloped, positive-sense, single strand RNA virus in the genus *Alphacoronavirus*, subfamily *Coronavirinae*, family *Coronaviridae*, of the *Nidovirales* order ([@bib0245]). Other recognised species in this genus are the porcine Transmissible Gastroenteritis Virus (TGEV), the human coronaviruses 229E, as well as various bat coronaviruses.

The PEDV genome is approximately 28 kb in length and inside the 5′ and 3′ untranslated regions (UTRs) encodes two overlapping non-structural polyproteins (nsp) ORFs 1a and b; the structural proteins spike (S), envelope (E), membrane (M) and nucleocapsid (N) and an accessory gene ORF3 ([@bib0255]). ORF1a produces the replicase polyprotein 1a; ORF 1b extends polyprotein 1a to polyprotein 1ab. Both polyproteins are cleaved to produce the nsp 1-16 ([@bib0255]).

The spike protein provides the corona-like appearance in electron micrographs that underlies the name of the viral family and mediates the entrance of virions into the cell. It comprises of five domains: a signal peptide; a S1 region, which facilitates the attachment of virions to cellular receptors; a S2 region, which mediates viral fusion to host cells; a transmembrane domain and a cytoplasmic tail. The S1 domain is further divided into two sub-domains: an N terminal domain and a C terminal domain, both of which may function as receptor binding domains ([@bib0280]). Porcine aminopeptidase N (pAPN) is the receptor for PEDV's entry to host cells ([@bib0260]). As the major envelope glycoprotein, the spike protein stimulates the induction of neutralising antibodies. [@bib0070] and [@bib0470] reported the CO-26K fragment (aa7-146) and the S1D region (aa636-789), respectively to contain one or more neutralising epitopes of PEDV. Subsequently, motifs within the S1 domain (YSNIGVCK, LQDGQVKI and MQYVYTPTYYML) and at the cytoplasmic tail (GPRLQPY) were suggested as neutralising or receptor binding epitopes ([@bib0475], [@bib0110], [@bib0060]).

PED was first described in England in the 1970s ([@bib0565]) and subsequently emerged across most of Europe, the historic events of which are summarised by Maurice Pensaert in this volume of *Virus Research*. PED is clinically similar to TGE of pigs mainly in young piglets characterised by watery diarrhoea sometimes preceded by vomiting ([@bib0405], [@bib0400]). While PEDV spread almost globally and reached South East Asia in the 1980s, clinical reports of PED declined in Europe and no cases have been reported from the field in GB since 2002 ([@bib0560]), whereas the virus still persisted in pockets of central Southern and Central Europe such as Italy until recently ([@bib0040]). Prototypic PED viruses isolated and used for further studies during the initial European epidemic included what was thought at the time to be separate strains CV777 and Br1/87 ([@bib0380], [@bib0170], [@bib0160], [@bib0050]). In general, PED outbreaks caused watery diarrhoea without significant mortality in growing pigs and sows and tended to spread rapidly through the herd. While it has been speculated that the appearance of Porcine Respiratory Coronavirus (PRCV), a strain antigentically closely related to TGEV, led to the disappearance of the latter, it has remained mysterious why PEDV has disappeared from countries such as GB, whereby the absence of surveillance programs does not exclude the circulation of milder forms in the past.

With the emergence of variant PEDV strains in China in 2010, its spread into the United States in 2013 ([@bib0480], [@bib0465]) and in the expectation of a re-emergence of PEDV in Europe we had reasons to revisit our historic knowledge and place it into current perspective.

2. Global emergence & spread {#sec0010}
============================

PEDV has been known to circulate in South East Asia since at least 1982; for example in Japan ([@bib0485]) with further records of the disease in China and Thailand since 2005 and 2007 respectively ([@bib0210], [@bib0385]). By late summer 2010, severe PED epizootic outbreaks had been detected in China that affected pigs of all ages but more severely the neonates ([@bib0265], [@bib0480]). These viruses seemed to be geographically restricted in China at first raising questions to which extent a highly virulent form was associated with local conditions, including the widespread circulation of other endemic pig viruses that are known to exacerbate PED, such as PCV-2 ([@bib0225]).

In spring 2013 highly virulent Chinese PEDV strains causing watery diarrhoea, vomiting and high morbidity with little loss in weaned pigs but high mortality in neonatal piglets was first observed in Iowa and Indiana, USA ([@bib0195], [@bib0465]). A full genome sequence was first published from a strain detected in Colorado in June 2013 ([@bib0315]) and for the purpose of this review, such strains will be referred to as Colorado-like PEDV viruses. In early 2014, a second variant of PEDV strains was discovered in Ohio, USA, showing minimal to no clinical signs at the time and no piglet mortality ([@bib0530]). Compared to other strains circulating in the USA this strain (OH851) showed 99% nucleotide (nt) identity at the full genome level and a 96% nt identity in the complete S gene, but only around 92% identity in the first 1170 nt of the S1 region ([Table 1](#tbl0005){ref-type="table"} ). Further to several point mutations, Ohio851 had one insertion and 3 deletions in this area of the genome, which is why such strains are commonly referred to as S-INDEL (insertion/deletion) variant strains. The closer relationship with other Chinese PEDV strains such as strain CH/HBQX/10, pointed towards the fact that these mutations did not occur in the USA, but rather that a second incursion into the USA had occurred ([@bib0525], [@bib0530]).Table 1Spike (S) amino acid homology of selected PEDV strains.Table 1![](fx1_lrg.gif)[^1]

Many further strains of PEDV have since been deposited in GenBank and described in the literature, particularly from North America. Among them another spike gene deletion (PEDV strain Minnesota188), which had a 2 amino acid (aa) deletion and further individual non-synonymous changes in the S2 region, demonstrating the emergence of new strains including such containing deletions from the pool of circulating field viruses ([@bib0320]). Since this isolate was closely related to the original USA/Colorado/2013 and not suggested to have a significantly altered pathogenicity it should not be considered separately from the clinical or impact perspective. For the purpose of this review we recognize two biological variants of the US/China PEDV viruses (Colorado-like; Ohio851-like) and reserve the term variant to make this distinction, whereby a variant requires a significant degree of genetic change and/or the demonstration of a significant biological change in behaviour. We do not distinguish here between isolates and strains, *e.g.* when discussing genetic data --- although strictly not many isolates have been obtained and lesser strains were maintained and characterized so far.

2.1. Further circulation and initial impact {#sec0015}
-------------------------------------------

Subsequent to the initial incursion into the USA, the Colorado-like PED-viruses crossed into Canada and Mexico as neighbouring countries ([@bib0525]) and further reports described the emergence of either or both PEDV variants in several countries in Asia: for example in October 2013 Japan reported the first outbreak of PED after a period of 7 outbreak-free years, likely imported from the USA ([@bib0445]) and further outbreaks of the disease were reported in South Korea, Taiwan, Thailand, Philippines, and Vietnam ([@bib0095], [@bib0240], [@bib0285], [@bib0495]). The European Food Safety Authority (EFSA) in their first report on PEDV ([@bib0125]) has compiled an extensive summary of PEDV detection up until the middle of 2014.

The first impression from a European perspective was that of a highly pathogenic virus and its very efficacious and efficient spread, causing devastating disease in many cases ([@bib0125]). However, at this point in time it was difficult to assess how the nature of the virus, farming practices including biosecurity and trade practices from farming goods to pork products contributed to the spread.

Multiple investigations and studies were carried out since to investigate the route by which the virus arrived in the USA. Feed was initially suspected, but subsequent investigations failed to show a common ingredient among the farms. In late spring 2014, a Root Cause Investigation Group (RCG) was tasked to identify the most likely mechanisms by which PED reached the US. The investigation concluded that flexible intermediate bulk containers (also known as "feed totes") provide a means to explain contamination of feed, entry into the USA and dissemination of the infection, compatible with herd investigations and assumptions regarding feed gathered ([@bib0425]). This does not, however, explain the local spread such as seen later across Europe, which can include various further mechanisms.

Estimates about the impact on pig industry in the US suggest that at least 7 million pigs died as a consequence of the infection in the first year of the epidemic alone ([@bib0550]) and recent figures show the infection of 2359 premises between June 2014 and March 2016 ([@bib0515]). In mid-2014, the net annual loss for U.S. economy from PED was estimated to range between \$900 million and \$1.8 billion ([@bib0360]) and could only partially be mitigated by finishing the remaining pigs for longer, since the outbreak impacted not only through high mortality in piglets but also through decreased performance of growing pigs weaned after the outbreak ([@bib0020]) as well as the impact on sow performance ([@bib0355], [@bib0115], [@bib0140], [@bib0290]). The full economic impact in the USA has even been further reaching, with effects on meat packers, processors, distributors and retailers due to reduced availability of pork, and on consumers due to the increase in pork prices ([@bib0420]).

2.2. European incursions, spread, circulating and extinct PEDV strains {#sec0020}
----------------------------------------------------------------------

Since spring 2014, outbreaks of diarrhoea affecting pigs of all age groups have also been reported in farms in Europe, firstly in Germany ([@bib0165], [@bib0155], [@bib0450]), followed by its neighbouring countries, the Netherlands, Belgium, and Austria ([@bib0500], [@bib0460]), as well as from the more distant Ukraine in summer 2014 ([@bib0115]). However, only the outbreak in the Ukraine was caused by a Colorado-like PEDV strain, whereas all the central European outbreaks were caused by the Ohio851-like variant. This in itself was interesting: whilst the Ukraine virus was at least spreading within the country at the time ([@bib0115]), it seemingly did not spread into neighbouring or central European countries. In contrast the Ohio851 variant spread further into Italy and Portugal ([@bib0330], [@bib0040]). However, as of June 2016 other central and Northern European countries remained completely free (such as Scandinavia) or like France reported only one single outbreak ([@bib0150]).

Overall in Central Europe, as in North America, morbidity and mortality were higher in piglets than in adult animals, sometimes reaching close to 100%. Clinical signs of PED were reported to last from 2 days in individual adult animals to up to 15 weeks in some piglet groups ([@bib0130]). Where details of the impact of the disease were reported, they included losses directly from piglet mortalities or euthanasia, decreases piglet per sow production and abortions, and reductions in average daily weight gains ([@bib0130]). However, it is an obvious observation that the overall impact in Europe, as a consequence of pathogenicity and spread, is so far significantly lower than in the USA, which raised questions, which factors contribute to the impact.

Given the range of clinical signs and disease patterns reported for apparently similar strains of PEDV, it is difficult to compare the pathogenicity or virulence of individual PEDV strains on the basis of literature reports. It was therefore desirable to carry out controlled *in vivo* studies to compare the viruses and evaluate their relative pathogenicity. Experimental infections have recently been carried out using defined virus strains. Further to establishing the proof of principle, most recent studies were able to use a molecular clone derived from strain PC22A to generate highly pathogenic viruses ([@bib0025]) and demonstrate the reduced pathogenicity of Ohio851-like variant strains compared to Colorado-like prototype viruses ([@bib0085]). Interestingly though, viraemia levels -- observed as a sign of viral spread across the animals -- was similar in both variants ([@bib0085]).

Intriguingly, however, not all attempts to infect pigs with PEDV have been successful recently. We aimed to infect 8 week old Large White X Landrace pigs orally in groups of six with either PEDV strain CV777 (group 1) or the Ukraine PEDV strain Poltova (group 2). CV777 virus was available in the form of culture supernatant already stored and the Ukrainian material was in the form of faeces obtained from the diagnostic case reported before ([@bib0115]). The amount of inoculum was adjusted by dilution with PBS on the basis of the Ct value in the real-time PCR (ranging from 13.38 to 16.15), so that each animal was to receive an equivalent amount of virus in a volume of 3 ml. Work was carried out under a Home Office (UK) licence along with approval from the Animal Welfare and Ethical Review Body at APHA and monitoring of clinical signs and sampling was carried out over 21 days. Unfortunately, no specific clinical signs were observed in any of the animals and none of the faecal samples tested were found to be positive for PEDV by qRT-PCR, nor did any of the animals seroconvert.

To account for the fact that the material had been diluted, possibly not representing the viral load available in the field, a second set of animals (4 each at 11 weeks of age) was infected with undiluted material containing 35--50× more virus than at the first attempt, this time absorbed into bread. The higher amount of virus was also to account for the fact that some of the material was possibly degraded through storage. The outcome, however, remained the same with no evidence of infection.

We finally tried to compensate for the fact that both the viruses (problems with shipment and storage) and/or the animals (age) might not have been ideal. For this purpose, two pigs of 6 weeks of age (just weaned and still on a special diet) were infected with the US isolate CO 136-025, kindly provided by Prof D. Werling and Dr R. Noad (RVC, UK). The virus had been grown over serial passage and we obtained cell culture supernatant from two passages (p2 and p3), which were used in the experiment. Tests confirmed the presence of a substantial, albeit lower amount of virus (ct values of 26 and 30). The material had been kept frozen at −80 °C since harvest and was only thawed at the time of use. Unfortunately, this attempt was not successful either.

Through personal communication, we are aware that these were not the only attempts on both sides of the Atlantic failing to establish infection in weaned pigs. We had considered post-weaned pigs advantageous for use in animal studies, as they were unlikely to succumb, consistent with 3Rs policies. Given that finishers and sows (thus older animals) were reported as affected in the field this age group could be considered susceptible.

However, all these incidental results together provide the basis for an alternative hypothesis: in that there was not enough infectious virus left to rescue. This hypothesis would also explain repeated reports from the field that back feeding of faecal material to sows failed to demonstrate a significant effect.

In contrast to other enteric viruses (*e.g.* Norovirus, Rotavirus, Hepatitis E virus), Coronaviruses and thus PEDV are enveloped viruses, which have a low resistance to environmental or chemical challenge. It may thus well be that PEDV stability is indeed limited and the virus cannot resist challenges such as those from the proteases present in faeces. Thus if the diarrhoeic material from clinical cases is not treated appropriately (*e.g.* immediate freezing at ultra-low temperatures or drying) the virus will lose its infectivity beyond recovery in due course. On the other hand, a recent observation indicated that weaned pigs require an around 1000× higher dose than non-weaned pigs for successful infection ([@bib0505]) and recent publications also described the failure to infect sows, while managing to infect piglets ([@bib0145], [@bib0295]). Together these observations further highlight that the spread of PEDV in the field is proportional to, if not dependent on, younger animals being involved.

Furthermore, we noted in the literature that those groups that succeeded in infecting pigs with PEDV have often used cell bound material from *in vivo* or *in vitro* propagation of the virus. This is mirrored by information from the field that minced intestines are far superior as material for back feeding in attempts to create herd immunity. While our results could be dismissed as a lack of opportunity to establish the viral load, we think that they rather reflect particular requirements of PEDV before reaching the target cells, *i.e.* the virus needs to be protected. *In vivo*, and for example during diarrhoea, parts of the mucosal cell layer are contained in the faeces, providing protection for PEDV. Those cells are however, subject to damage by many procedures that preceded our infection (transport, storage, harvesting virus from supernatant) that was mimicking the natural route of infection, which in weaned pigs includes a passage through the stomach. It has to be noted that most of the above-mentioned, successful infections use orogastric inoculation as a means to ensure reproducible infection, which is, however, not reflective of the field situation.

Another way of assessing the threat of emerging variants from the global PEDV circulation was to assess strain differences between known strains such as CV777, review our historical archive of strains and analyse the heterogeneity of PEDV in field material.

A 15 year analysis of Korean PEDV strains observed little genetic variation ([@bib0240]), which demonstrates a rather slow evolution and maintenance of fitness by accruing recombination and/or mutations. This supports the idea of high fidelity replication in coronaviruses due to the presence of 3′ to 5′ proofreading endonuclease activity, which maintains the stability of the viral genome ([@bib0435]). Similarly, CV777 and material thereof that was for almost a decade (until 1987) passaged in pigs in GB (at APHA) before being sent to DTU, Denmark, where it was further passage twice in pigs before being isolated as Br1/87 ([@bib0160], [@bib0050]), demonstrate only few changes over the decades of maintenance *in vivo* and *in vitro* ([Table 2](#tbl0010){ref-type="table"} ).Table 2Spike (S) amino acid homology of selected isolates of PEDV CV777.Table 2![](fx2_lrg.gif)[^2]

While the genetic drift of *Coronaviruses* is relatively slow, two events need to be accounted for. Firstly recombination and deletion events across the genome (not only in the S gene) contribute significantly to the overall evolution of PEDV ([@bib0395], [@bib0325], [@bib0205]). While most of these recombination were with other PEDV strains ([@bib0510], [@bib0275]), recent reports from Italy and Germany highlighted the ability of PEDV to exchange sequences with other Coronaviruses, here TGEV ([@bib0040], [@bib0005]), leading to the creation of novel alpha-Coronavirus, tentatively named swine enteric Coronavirus (SeCoV), not further considered here since its backbone is mainly TGEV rather than PEDV.

Secondly, the scale and the size of the outbreaks in modern pig production units cannot be regarded as one *in vivo* passage per outbreak. Rather, upon the first incursion the virus undertakes some (few) passages while spreading across the unit, but subsequently leads to a mass production and secretion of virus from one generation of piglets to the next as long as the virus is not controlled, which in some cases was for months, creating a cloud of viruses. When further analysing a single NGS sample from the Ukraine outbreak, that delivered the consensus sequence published ([@bib0115]) we found several areas of mutational hot-spots in, but not exclusively limited to the S gene (*e.g.* positions 1312--1382, 1782--1822, 1922--1972, 2022--2072, 2222--2272, 2822--2852, 3022--3072, 3532--3572, 3672--3722) with evidence for 29 SNPs therein, each underpinned by several reads, clearly indicating a slow but steady evolution during such outbreaks.

While most of the historic material held in our storage is from earlier passages of CV777, we also had material from one of the last GB PEDV cases in the year 2000 available for analysis ([@bib0455]). This PEDV strain, termed England-1-2000, is indeed significantly different not only to CV777, but also to all other previously known strains and can be seen as a prototype of a further genotype of PEDV ([Fig. 1](#fig0005){ref-type="fig"} ). This and other recently identified PEDV strains, such as the PEDV strain circulating in Italy in 2009 ([@bib0040]) also provide the basis for an update of the previously proposed nomenclature of PEDV genotypes ([@bib0195]), whereby Genotype 1 is formed through a distinct clade comprising the prototype strain CV777 and related strains circulating in Asia until recently at least, but also a second group of viruses from Asia, which points towards an older ancestor of this genotype. Genotype 2 has various clades arising, which are statistically fully supported by high bootstrap values, amongst them individual strains from China that are not closely related to the highly pathogenic strains. To which extend these subgroups in both Genotype 1 and 2 will prevail is not certain, as they are likely many PEDV strains not fully sequenced yet. We are thus not favouring any further division --- also since these are currently not underpinned by antigenetic or biological differences. However, the strain from Italy mentioned above is succinctly different to both genotypes 1 and 2 so that it warrants to be kept separate and by genetic distance would be the prototype of genotype 3. We see not merit in calling a genotype R (recombinant) since recombination between strains is a common event among Coronaviruses. It thus seems more meritorious to accept this clade as genotype 4, being similarly distant from the others. Finally the strain England-1-2000 is significantly different to all other PEDV strains known so far and can be seen as the prototype of Genotype 5 ([Fig. 1](#fig0005){ref-type="fig"}).Fig. 1Phylogenetic analysis of 40 representative PEDV full genome RNA sequences. The evolutionary history was inferred by using the Neighbor-Joining method, as described by [@bib0195]. Evolutionary analyses were conducted in MEGA6 ([@bib0490]). Accession numbers, country and year of isolation are indicated, as provided by GenBank and the references therein. The resulting genotypes are numbered and colour-coded. A) Percentage identity/differences across the different genotypes. The genetic differences between genotypes are at least 2.5% as highlighted in the light blue box using the prototype PEDV strain CV777 as reference. This table also demonstrates that PEDV England-1-2000 (Genotype 5) is more diverse to any other genotype than these are to each other (\>4.5%, pink box). B) The tree is drawn to scale, except for the out-groups bat coronavirus (BatCoV), porcine respiratory coronavirus (PRCV) and transmissible gastroenteritis virus (TGEV), which are shown for reference. Branch lengths other than the out-groups reflect the number of substitutions per site. The percentage of trees in which the associated taxa clustered together is shown next to the branches for values greater than 70%. Genotypes 1 and 2 are as inferred by [@bib0195]; Genotype 3 is represented by the recently sequenced Italian strain from 2009, while Genotype 4 is represented by two strains derived from recombination thus previously termed R ([@bib0195]). Genotype 5 is represented by the strain England-1-2000, the most distinct PEDV strain discovered so far.Fig. 1

To which extent the genetic variation limits the immunity conferred by infection or vaccination remains to be determined. Antibodies (Abs) are most important to protect newborn piglets in particular, and maternally-derived, colostral-transferred Abs that neutralise PEDV (neutralising Abs, nAbs) confer protection to newborn piglets ([@bib0445]). However, not only has the efficiency of existing live-attenuated vaccines been discussed critically ([@bib0445]), there is also evidence that vaccine strains might escape and further evolve, not least through recombination with other field strains ([@bib0440]). Furthermore, it has been demonstrated that genetic variability in the spike protein not only affects the pathogenicity as discussed above, but also occurs within areas correlated to neutralisation, specifically the CO-26K fragment ([@bib0445]). Here, further studies are required to determine if particular mutations occurring within the spike protein have a significant impact upon the binding of nAbs, limiting cross-protection between strains in particular.

3. Challenges for the control of PEDV {#sec0025}
=====================================

PEDV cannot be diagnosed on the basis of clinical findings --- not least since there are far too many similar Coronavirus infections. The early identification of PEDV was carried out through electron microscopy ([@bib0380]) before the virus had even been isolated.

While virus isolation is no longer the gold standard for disease confirmation, it remains an important tool for studying strains to determine the existence of biological variants. However, PEDV is notoriously difficult to isolate ([@bib0075]) and its propagation causes specific challenges.

The first adaptation of PEDV to enable growth in Vero cells by serial passage was reported in 1988 and the addition of trypsin to the cell culture medium has since been found to be essential for virus isolation and passage ([@bib0170], [@bib0540]). This trypsin-dependence, which seemingly mimics the situation in the small intestines, has been the subject of several subsequent studies that found it to be critical for the cleavage of the spike (S) protein which mediates activation of membrane fusion ([@bib0375], [@bib0555]). In addition, trypsin is required for virus-induced haemagglutination ([@bib0370]), and also for cell-to-cell fusion and syncytia formation, which precedes the lytic cytopathogenic effect ([@bib0170], [@bib0555]). Thus, trypsin is required for multi-cycle replication, *i.e.* without proteases clusters of virions were retained on the cell surface ([@bib0430]) hence the maintenance of cell cultures during infection becomes more challenging.

Pig intestinal epithelial cells (IEC), representing a natural target cell, could be infected with PEDV (CV777), but interestingly were less susceptible than green monkey Vero E6 cells ([@bib0100]). Furthermore, PEDV has been shown to infect a range of other cells, such as Vero CCL-81, human liver (Huh-7), human lung (MRC-5), porcine kidney (PK-15), swine testis (ST), as well as bat lung (Tb1-Lu) cells ([@bib0055]). These studies were also able to confirm earlier reports that aminopeptidase N (APN), CD13, from both porcine and other species, acts as the cellular receptor for PEDV that upon transfection can render non-permissive cells (such as MDCK) permissive and that N-acetylneuraminic acid (Neu5Ac) is a co-receptor, such as described for other alpha-Coronaviruses ([@bib0260], [@bib0100], [@bib0055]). However, as PEDV ultimately enters via clathrin-mediated endocytosis, independent of caveolae-coated pit assembly ([@bib0200]), other receptors and co-receptors are conceivable, such as heparan-sulfate ([@bib0190]), which is widely expressed on macrophages for example and PEDV has been shown to infect porcine alveolar macrophages *in vitro* and *in vivo*, which may be a secondary target upon the well described viraemia ([@bib0365], [@bib0085]).

It is worth noting, however, that there were significant differences between the levels of PEDV protein expression between susceptible cell lines mentioned above. ST and PK-15 cells for example showed only a very limited infection at low infection dose with slight increase in MRC-5 and Tb1-Lu, while Vero CCL-81 and Huh-7 cells were seemingly comparable in their infection ([@bib0055]). This is in line with [@bib0100] demonstrating the need for a much higher moi10 to be used for an efficient infection of IEC. It also has to be taken into account that some reports (such as [@bib0055]) only investigate the uptake of PEDV and protein expression, not the complete replication, *i.e.* by determining the resulting titres. Thus it is quite possible that some cells rather display an abortive infection cycle than promoting virus production. The impact of viral strain variation has not been much further evaluated so far, but it has been suggested that primary isolates might grow preferably in IEC ([@bib0100]).

In our attempt to rescue the Ukrainian PEDV strain, we reviewed several components of the original Vero cell protocol as the combination of trypsin, yeast extract and tryptose phosphate broth seemed a very unlikely combination required, with no explanation provided for the latter two components ([@bib0170]). While trypsin was required to increase the resulting viral titres, it could be abandoned after infection, whereas yeast extract was required for cell viability when trypsin was added. Tryptose phosphate broth on the other hand increased the slightly detrimental effect of trypsin to the cell culture, but its absence also correlated with a decrease in cytopathogenic effect (cpe). There are, however, alternatives on the market now, such as the ultra-MDCK medium (Lonza), which did not require any other additives than trypsin and antibiotics and resulted in similar viral titres, albeit slightly smaller sized plaques compared to the standard medium (data not shown).

Intriguingly, there are at least three clones of African green monkey (*Chlorocebus sabaeus*) kidney (Vero) cells, which have been used for PEDV infections: the original Vero cell line isolated in 1962 (ATCC CCL-81) has been widely used (*e.g.* [@bib0170], [@bib0555], [@bib0540], [@bib0075], [@bib0055]). Vero 76 cells were derived from these in 1968 and have rarely been used for PEDV propagation ([@bib0350]). Vero E6 (also referred to as Vero C1008) is a clone of Vero 76 cells, derived in 1979, also successfully used for PEDV culture ([@bib0100]). The two subclones of the original Vero cell line are slower-growing cells, which exhibit some degree of contact inhibition (according to the ATCC website). The differences between Vero CCL-81 and Vero E6 in PEDV infection remain unclear, but in our hands Vero CCL-81 were by far superior to E6 in propagating CV777 to a lytic replication.

The reason for Vero cells being uniquely superior to other cells have not been full elucidated and it has mainly been suggested that receptor density of CD13 plays a key role, since CD13 overexpression rendered ST cells more susceptible to PEDV infection ([@bib0340]). Another key feature of Vero cells, however, is their inability to produce type I interferon (IFN-I), which might limit coronavirus infection ([@bib0120]). To test the impact IFN deficiency has on PEDV replication we used a PK-15 line stably transfected with CSF~n-pro~ (kindly provided by Dr S.A. La Rocca, APHA), a protein known to inhibit IFN production if overexpressed. There was, however, no difference between the PK15 cells and the PK15~n-pro~ cells and we are able to confirm that PK-15 are relatively refractory to Vero cells, but not resistant, requiring a 10× higher concentration than Vero cells to propagate the virus (data not shown), which led the original isolation team to conclude that PK-15 were non-permissive ([@bib0170]). However, while PK15 became infected at high concentration and developed a cpe we did not manage to rescue virus from the supernatant. Also when reviewing the Vero cell replication we had noted that a virus titres obtained from serial titration was not reproducible when trying to plate out a distinct number of plaque forming units.

Whilst problems to isolate the virus were traditionally attributed to faecal inoculums and maintenance of the cells with trypsin containing medium, our results are in line with the general observation by both our US and European colleagues that the isolation and maintenance of PEDV is extremely challenging. In one recent study 68 attempts to rescue a PEDV S-INDEL-variant strain from clinical material failed and virus isolation was only successful from small intestine homogenates or cecum contents ([@bib0090]). This suggests that the key to successful PEDV isolation lies in a high concentration of the virus in the sample as well as immediate virus isolation from fresh samples, which supports our earlier hypothesis that viable virus requires protection and that upon transport and storage the amount of viable virus is often significantly reduced, thereby emphasizing the relatively low tenacity of PEDV ([@bib0175], [@bib0220], [@bib0390]), which does not necessarily affect the detection of viral RNA by RT-PCR ([@bib0215]), but neither does the successful application of disinfectants ([@bib0045]).

Since virus isolation as a reliable routine method for the detection of PEDV is not an option, other tests are more important. Several assays have been developed for the detection of the virus. Recently, antigen-capture ELISA's based on the monoclonal antibody 5D7 were suggested to have a sensitivity and specificity comparable to RT-PCR at detecting clinical disease ([@bib0545]). Lateral flow pen-side devices are also available to confirm clinical suspicion of PEDV where rapid access to a diagnostic laboratory is limited, and were used for example to confirm suspicion of PEDV in Ukraine ([@bib0115]).

Detection of the viral RNA through RT-PCR, however, has become the gold standard for PEDV detection. Several of such PCR assays including real-time (qPCR) assays have been described in the literature (*e.g.* [@bib0230], [@bib0440]) and commercial test kits have been developed after the outbreak in the USA not least. An interesting concept thereby is the detection of several enteric porcine viruses, or different porcine Coronaviruses, as now exist with PEDV, TGEV, SeCoV and the Delta-Coronavirus, depending on geographical requirements ([@bib0235], [@bib0035]). From our perspective, there seems to be little merit, however, in trying to discriminate Colorado-like and Ohio-like strains or recent and classical PEDV variants ([@bib0535], [@bib0575]), as there is no difference for the control arising. Insulated isothermal amplification systems do not offer the ability to multiplex, but might provide the opportunity to deploy tests in the field in countries where laboratories are not easily accessible ([@bib0570]). Importantly, it has to be taken into consideration that some of the early PCR primers, designed on the available virus sequences at the time, may no longer be suitable for detection of the new virus variants.

Considering the high virus load excreted by acutely affected pigs a range of qPCR assays were feasible to detect disease. It needs to be considered, though, that testing in an outbreak might also include environmental sampling to trace the origin of the outbreak. Also as shedding in older animals has been demonstrated to occur for quite some time after infection ([@bib0105], [@bib0310]), it has to be considered that sensitive qPCRs might be required to detect carriers of infection, such as relevant for trade and tracing purposes. For this purpose, test sensitivity needs to be a focus of the analysis ([@bib0335]).

In order to trace infections and to allow for biosecurity and control measures to be implemented, it is also helpful to determine the genetic composition of PEDV from each outbreak. While traditionally PCRs in combination with Sanger sequencing would have been used, next generation sequencing (NGS) has recently been applied extensively (*e.g.* [@bib0115]; [@bib0155]) and can be used to determine recombination events as seen in Italy alike. The widely used Illumina or IonTorrent technologies, however, are still prohibitively expensive to make this approach affordable. Latest technologies, such as the MINIon, however, could provide a breakthrough for the wider applicability of sequencing technologies into the control toolbox.

In order to assess the on-going situation in Europe it may be of value to implement serological testing, *e.g.* for confirming freedom from infection and to enhance trade of live pigs.

While variation in the S glycoprotein has been related to attenuation *in vivo* and growth adaptation *in vitro* ([@bib0415], [@bib0080]), there appears to be only a single PEDV serotype to date. Thus virus neutralisation (VN) as a well-characterised method is feasible, but is comparatively demanding due to the cell culture requirements discussed above and time-consuming ([@bib0345]). However, the sensitivity of the VN allows for the detection of PEDV antibodies as early as 7 dpi ([@bib0505]). An adaptation of the assay, as Fluorescent Focus Neutralisation (FFN) assay, is a more rapid assay measuring infection through labelling infected cells rather than waiting for cpe ([@bib0350]).

To screen larger herds, though, high-throughput technologies, such as ELISAs are more appropriate. The first ELISA described for PEDV used cell-culture grown PEDV as antigen and was considered more specific and sensitive test than indirect immunofluorescence at the time ([@bib0180]). Immunoperoxidase monolayer assay (IPMA), however, can detect the presence of the virus as early as 6dpi ([@bib0545]) and offers the ability to verify the result not only by quantity (titre), but also be quality (specificity of the staining). While earlier indirect ELISAs were based on whole virus preparations ([@bib0250], [@bib0345]), more recently developed indirect ELISA's are based on recombinant forms of viral membrane, N or S proteins ([@bib0135], [@bib0185], [@bib0270]). Alternatively blocking ELISA's are used and have been postulated to have greater levels of specificity and sensitivity when compared with other assays ([@bib0520], [@bib0065]). To bridge the contrasting requirements for high specificity and high sensitivity has always been a challenge for ELISAs and unfortunately none of the ELISAs has so far been further validated, *e.g.* against the ISO standard 17025 and our experience so far suggests that neither blocking nor indirect ELISAs are matching requirements for single animal analysis.

Fluorescent microsphere immunoassay (FMIA) or Luminex assays promise simpler setup with the ability to detect several pathogens simultaneously and a recently developed PEDV assay showed the highest specificity and was able to detect antibodies earlier than the ELISAs ([@bib0350]).

4. Conclusions {#sec0030}
==============

Despite a considerable amount of research not least in recent years, PEDV remains an enigmatic virus with complex requirements for replication that render it difficult to draw conclusions that can be translated from the laboratory to the field. International collaboration has been a key factor for progress not least in Europe, but is limited on a global scale with too few funding opportunities for diseases such as PEDV that are not recognised priorities, which contribute to the vulnerability towards globally emerging viruses.

Fortunately, the re-emergence of PEDV in Europe has not had similar devastating effects as in the US or China, but its economic impact and potential must not be underestimated ([@bib0130]). With rapid technologies for the detection of PEDV in place, effective control measures can be designed and various pieces of evidence discussed above, such as the limited spread in Europe, the low tenacity of the virus and the effective measures for disinfection support the Canadian experience *i.e.* strict biosecurity measures are able to control outbreaks ([@bib0305]).

Consequently, the biggest challenges in the re-emergence of PEDV seem to be associated with pig producing practices, many of which are not common in central Europe. One way by which PEDV overcomes the limitation of its low tenacity is the amount of virus produced during an outbreak. Taking the qPCR values into account PEDV is more than 1000 and possible up to 100,000 fold more concentrated in pig faeces than other pig viruses such as PRRSV in other pig secretions (such as saliva for PRRSV). This, plus the scale of diarrhoea per piglet plus the number of piglets per sow (with a dissemination rate close to 100%) and the scale of some pig production units, where thousands of piglets are produced per week ([@bib0115]) created an almost unimaginable amount of virus under some circumstances, where even a high dilution of starting material still suffices to transmit virus effectively --- including to older pigs which are more resistant. Even the possibility of airborne spread to close-by farms has to be considered as a route of virus transmission under those circumstances ([@bib0010], [@bib0015], [@bib0030]; [@bib0115]). Other routes of transmission between close by farms include contaminated trucks ([@bib0300]), equipment, or people and it has been determined that the risk is associated with proximity to an infected farm, which in turn correlates with the time the virus maintains its viability ([@bib0410]).

Best practice in preparation of an incursion into countries with a naïve population, such as the UK remains to focus on horizon scanning of suspect cases and biosecurity practises to enable local control, in particular in the absence of a registered vaccine that could be of additional assistance, hence a key in this concept is the ability of highly sensitive tests to detect the low level shedding in pigs that do not succumb as it might occur for a prolonged period.
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[^1]: The Colorado and Ohio851 strains resemble prototypic variants of US/Chinese PED viruses, and are most different to previous European strains. The Minnesota strain discussed in the text does not discriminate itself significantly from the Colorado strain. Also apparent is the homology between the Ohio851 variant and a strain detected previously in China (CH_HBXQ_10), which is evidence for two incursions into the USA. A) is the full S-protein sequence, B) the S1 region only.

[^2]: Strains of CV777 were maintained in various labs around the globe, passaged partially *in vivo* and *in vitro* as discussed in the text. The original CV777 (GenBank AccNo [NC_003436.1](ncbi-n:NC_003436.1){#intr0005}) and its derivatives maintained through sequential passage in pigs or Vero cells (CV777 APHA and Br1/87/GenBank AccNo [Z254831](ncbi-n:Z254831){#intr0010}) are almost identical, demonstrating their common origin. Only the presumed Chinese CV777 vaccine strain (GenBank AccNo [KT323979](ncbi-n:KT323979){#intr0015}, for which the authors could not find further history), whose S-protein is in fact almost identical to the Korean strain DR13 (GenBank AccNo [DQ462404](ncbi-n:DQ462404){#intr0020}) is different, raising questions about the provenance and relation to this strain.
